Northrop Grumman to Post Q4 Earnings: Here's What You Need to Know

21.01.26 14:13 Uhr

Werte in diesem Artikel
Aktien

564,60 EUR 3,40 EUR 0,61%

Indizes

6.843,5 PKT 46,7 PKT 0,69%

Northrop Grumman Corporation NOC is scheduled to report fourth-quarter 2025 results on Jan. 27, before market open. The company delivered an earnings surprise of 18.18% in the last reported quarter.Let’s discuss the factors that are likely to be reflected in the upcoming quarterly results.Key Factors Likely to Influence NOC’s Q4 ResultsNorthrop Grumman’s fourth-quarter results are expected to benefit from solid execution across all of its business segments, aided by resilient defense demand and rising global defense expenditures.Strength across the Aeronautics Systems, Mission Systems and Defense Systems segments, supported by a steady ramp-up of major programs, particularly the B-21 Raider and missile defense, is expected to have positively influenced the company’s revenue performance in the quarter to be reported. Improved productivity and easing supply-chain constraints are likely to have supported fourth-quarter earnings. However, higher corporate unallocated expenses and the federal tax rate may have weighed on the company’s bottom line.Northrop Grumman Corporation Price and EPS Surprise Northrop Grumman Corporation price-eps-surprise | Northrop Grumman Corporation QuoteNOC’s Q4 ExpectationsThe Zacks Consensus Estimate for revenues is pinned at $11.62 billion, indicating a year-over-year improvement of 8.7%.The Zacks Consensus Estimate for earnings is pegged at $6.99 per share, calling for a year-over-year increase of 9.4%.Regular contract wins and improving international demand should further enhance backlog conversion. The Zacks Consensus Estimate for NOC’s fourth-quarter backlog stands at $99.87 billion, up 9.2% year over year.What the Zacks Model Unveils for NOCOur proven model predicts an earnings beat for NOC this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here, as you will see below.Earnings ESP: NOC has an Earnings ESP of +0.54%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.Zacks Rank: NOC currently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.Stocks to ConsiderBelow, we have mentioned players from the same industry that have the right combination of elements to beat on earnings in the upcoming releases.GE Aerospace GE is set to report fourth-quarter 2025 earnings on Jan. 22, before market open. It has an Earnings ESP of +1.98% and a Zacks Rank of 3 at present.The Zacks Consensus Estimate for GE’s earnings is pegged at $1.42 per share, indicating year-over-year growth of 7.6%. The consensus estimate for its sales stands at $11.26 billion, calling for year-over-year growth of 14%.The Boeing Company BA is set to report its fourth-quarter 2025 results on Jan. 27, before market open. It has an Earnings ESP of +16.73% and a Zacks Rank of 3 at present.The Zacks Consensus Estimate for BA’s earnings is pegged at a loss of 39 cents, indicating a year-over-year rise of 93.4%. The consensus estimate for its sales is pegged at $21.74 billion, suggesting year-over-year growth of 42.6%.Draganfly Inc. DPRO is expected to report its fourth-quarter 2025 results soon. It has an Earnings ESP of +13.33% and a Zacks Rank of 2 at present.The Zacks Consensus Estimate for DPRO’s earnings is pegged at a loss of 15 cents, which suggests an increase of 81%. The consensus estimate for its sales is pegged at $1.66 million, indicating year-over-year growth of 44.4%.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA): Free Stock Analysis Report Northrop Grumman Corporation (NOC): Free Stock Analysis Report GE Aerospace (GE): Free Stock Analysis Report Draganfly Inc. (DPRO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Northrop Grumman

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Northrop Grumman Corp.

Wer­bung

Analysen zu Northrop Grumman Corp.

DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
19.05.2016Northrop Grumman Sector PerformRBC Capital Markets
02.05.2016Northrop Grumman Equal WeightBarclays Capital
30.04.2015Northrop Grumman NeutralUBS AG
12.02.2015Northrop Grumman Equal WeightBarclays Capital
19.10.2012Northrop Grumman performOppenheimer & Co. Inc.
DatumRatingAnalyst
13.09.2012Northrop Grumman sellUBS AG
14.06.2006Update Northrop Grumman Corp.: UnderperformGoldman Sachs

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen